Evaluation of C-reactive protein as predictor of adverse prognosis in acute myocardial infarction after percutaneous coronary intervention: A systematic review and meta-analysis from 18,715 individuals
BackgroundProper prognostic biomarker is of great importance for clinical decision-making in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). Although recently emerges plenty of novel inflammatory biomarkers, the canonical inflammatory mediator C-r...
Main Authors: | Shijie Liu, Hongcheng Jiang, Menaka Dhuromsingh, Lei Dai, Yue Jiang, Hesong Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1013501/full |
Similar Items
-
Use of intravascular ultrasound for optimal vessel sizing in chronic total occlusion percutaneous coronary intervention
by: Recha Blessing, et al.
Published: (2022-08-01) -
Prognostic Impact of Multiple Prior Percutaneous Coronary Interventions in Patients Undergoing Coronary Artery Bypass Grafting
by: Fausto Biancari, et al.
Published: (2018-10-01) -
Late Myocardial Infarction and Repeat Revascularization after Coronary Artery Bypass Grafting in Patients with Prior Percutaneous Coronary Intervention
by: Fausto Biancari, et al.
Published: (2022-09-01) -
Original paper<br>C-reactive protein as a predictor of major adverse cardiac events (MACE) after percutaneous coronary intervention?
by: Leszek Markuszewski, et al.
Published: (2005-11-01) -
Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
by: Gábor Csató, et al.
Published: (2022-07-01)